The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception 1,2 . Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT 2A receptors (2AR) 3, 4 . Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia [5] [6] [7] . The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR 8-10 and resemble some of the core symptoms of schizophrenia [10] [11] [12] . Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G-protein-coupled receptor family, to form functional complexes in brain cortex. The 2AR-mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen-specific signalling and behavioural responses. In post-mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR-mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.
The psychosis associated with schizophrenia is characterized by alterations in sensory processing and perception 1, 2 . Some antipsychotic drugs were identified by their high affinity for serotonin 5-HT 2A receptors (2AR) 3, 4 . Drugs that interact with metabotropic glutamate receptors (mGluR) also have potential for the treatment of schizophrenia [5] [6] [7] . The effects of hallucinogenic drugs, such as psilocybin and lysergic acid diethylamide, require the 2AR [8] [9] [10] and resemble some of the core symptoms of schizophrenia [10] [11] [12] . Here we show that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G-protein-coupled receptor family, to form functional complexes in brain cortex. The 2AR-mGluR2 complex triggers unique cellular responses when targeted by hallucinogenic drugs, and activation of mGluR2 abolishes hallucinogen-specific signalling and behavioural responses. In post-mortem human brain from untreated schizophrenic subjects, the 2AR is upregulated and the mGluR2 is downregulated, a pattern that could predispose to psychosis. These regulatory changes indicate that the 2AR-mGluR2 complex may be involved in the altered cortical processes of schizophrenia, and this complex is therefore a promising new target for the treatment of psychosis.
The 2AR and mGluR2/3 show an overlapping distribution in brain cortex in autoradiography studies 13 . The mGluR2 and mGluR3 are not distinguished by autoradiographic ligands. We used fluorescent in situ hybridization (FISH) to determine whether either of these receptor subtypes is co-expressed by the same neurons. In layer V mouse somatosensory cortex (SCx), cells positive for 2AR mRNA were mostly positive for mGluR2 mRNA. The level of expression in SCx was much lower for mGluR3 mRNA, which rarely co-localized with 2AR mRNA (Fig. 1a) . Control studies validated the sensitivity and specificity of the assay, and similar 2AR-mGluR2 mRNA co-localization was found in cortical primary cultures (Fig. 1a-c and Supplementary Fig. 1 ). Translation of 2AR protein in cortical pyramidal neurons was found to be necessary for normal mGluR2 expression. Mice with globally disrupted 2AR expression (htr2A 2/2 mice) showed reduced cortical mGluR2 binding and expression, whereas mice in which 2AR expression had been selectively restored in cortical pyramidal neurons 8, 14 showed expression levels equal to those in the control (Supplementary Table 1 and Supplementary Fig. 2 ). The effects of mGluR2/3 activation on 2AR responses have generally been attributed to synaptic mechanisms 5, 6, 13, 15 . However, the co-localization of 2AR and mGluR2 and the decrease in mGluR2 expression levels in htr2A 2/2 mice led us to examine whether a direct mechanism contributed to cortical crosstalk between these two receptor systems.
Recent studies have demonstrated that some G-protein-coupled receptors (GPCRs) belonging to the same sequence classes can form dimers 16 or, potentially, higher-order oligomers 17 . Although the 2AR and mGluR2 belong to different GPCR classes, we established the existence of 2AR-mGluR2 heterocomplexes by several methods: coimmunoprecipitation of human brain cortex samples (Fig. 1d) and of HEK-293 cells transfected with epitope-tagged receptors (Fig. 2b) , bioluminescence resonance energy transfer (BRET) ( Fig. 1e and Supplementary Fig. 3 ), and fluorescence resonance energy transfer (FRET) (Fig. 2d ) studies in transfected cells.
To determine whether the formation of the 2AR-mGluR2 complex has functional consequences, we first examined, in mouse SCx membranes, the effects of an mGluR2/3 agonist on the competition binding of several hallucinogenic 2AR agonists (Fig. 1f, top) and of a 2AR agonist on the competition binding of several mGluR2/3 agonists (Fig. 1f, bottom) . The agonist affinities for the 2AR and mGluR2/3 were decreased when receptor-G-protein complexes were uncoupled by GTP-cS ( Supplementary Fig. 4 and Supplementary Tables 2 and 3 ). The glutamate agonist LY379268 increased the affinity of all three hallucinogens studied for the 2AR-binding site. Furthermore, the 2AR agonist DOI (1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane) decreased the affinity of the three mGluR2/3 agonists for the glutamate-receptor-binding site. The allosteric interactions observed were eliminated by antagonist for each modulator (see Supplementary Tables 2 and 3 and Supplementary Fig. 4 for additional concentrations of DOI and LY379268 and for the elimination of the allosteric effects by antagonists). Although the glutamate agonists studied do not distinguish between the mGluR2 and mGluR3 subtypes 18 , the rarity of mGluR3 and 2AR mRNA co-expression in cortex, the absence of evidence for 2AR-mGluR3 complex formation by co-immunoprecipitation, BRET and FRET, and the detection of 2AR-mGluR2 complexes by these same assays all indicate that the cross-talk identified results from 2AR-mGluR2 complexes.
The differences in the capacity of the mGluR2 and mGluR3 to interact with the 2AR and their close sequence similarity provided the basis for identifying the specific mGluR2 domains responsible for heterocomplex formation. A study of a series of molecular chimaeras of the mGluR2 and mGluR3 (see Fig. 2a ) demonstrated that the segment containing transmembrane (TM) helices 4 and 5 of the mGluR2 receptor was both necessary and sufficient for the formation of a complex with the 2AR. The mGluR3 receptor chimaera containing only this segment from the mGluR2 (mGluR3DTM4,5) was capable of co-immunoprecipitating with the 2AR (Fig. 2b) , mediating allosteric cross-talk (Fig. 2c) and maintaining close proximity with the 2AR as indicated by FRET (Fig. 2d) . In contrast, mGluR2DTM4,5 did not show evidence of complex formation with the 2AR (Fig. 2 Tables 4 and 5 show complete curves, analysis and evidence of membrane expression of all chimaeras). The absolute and relative levels of expression of heterologous constructs were comparable to the physiological levels found in mouse SCx, and in cortical primary cultures (Supplementary Fig. 5 and Supplementary Table 4 ). Our data do not exclude the possibility that the predicted 2AR-mGluR2 heterodimer, a model of which is shown in Fig. 2f , assembles into tetramers or larger receptor oligomers 19, 20 . The changes in high-affinity binding caused by 2AR-mGluR2 cross-talk suggested that this complex may serve to integrate serotonin and glutamate signalling and modulate G-protein coupling 21, 22 . This hypothesis was tested by measuring the regulation of Ga q/11 and Ga i proteins by 2AR. High-affinity activation of Ga q/11 by the 2AR was decreased by co-expression of mGluR2 ( Fig. 2e and Supplementary Table 6 ). The activation of Ga i by the 2AR was markedly enhanced by mGluR2 co-expression ( Fig. 2e and Supplementary Table 7 ). The mGluR2-dependent effects on both Ga q/11 and Ga i regulation by the 2AR were reversed in the presence of mGluR2 agonist (Fig. 2e and Supplementary Tables 6 and 7) . Consonant with the results from co-immunoprecipitation, allosteric modulation and FRET, the functional assays of G-protein activity also show that the TM4-5 segment of the mGluR2, when substituted into the mGluR3, was sufficient for signalling cross-talk to occur (Fig. 2e) . These data support the presence of functional and physiological 2AR-mGluR2 complexes that integrate serotonin and glutamate neurotransmission to specify the pattern of G-protein regulation.
Similar evidence for specification of G-protein subtype regulation was also observed for the endogenous brain 2AR-mGluR2 complex Fluorescence/luminescence with membranes from cortical primary cultures (Fig. 3a) . The pattern of G-protein regulation in cortical pyramidal neurons has been shown to predict specific behavioural responses to 2AR agonists. Hallucinogenic drugs and non-hallucinogenic drugs activate the same population of 2ARs in cortical pyramidal neurons but differ in the 2AR-dependent pattern of G-protein regulation and gene induction that they elicit 8, 9 . In brain cortical neurons, the signalling elicited by hallucinogenic and non-hallucinogenic 2AR agonists causes the induction of c-fos and requires G q/11 -dependent activation of phospholipase C. However, the signalling of hallucinogens such as DOI and lysergic acid diethylamide (LSD) acting at the 2AR also induces egr-2, which is G i/o -dependent. Thus, c-fos expression results from any 2AR signalling, and egr-2 induction is a specific marker for hallucinogen signalling through the 2AR 8, 9 . The finding that mGluR2 modulates the coupling of the 2AR to G i (Fig. 3a and (Fig. 3b and Supplementary Figs 8-10) was not affected by the mGluR2/3 agonist LY379268. In contrast, the hallucinogen-specific induction of egr-2 was selectively blocked by LY379268 in both mouse cortex in vivo and in primary cortical cultures ( Fig. 3b and Supplementary Figs 8-10 show FISH results with LSD treatment, and real-time PCR gene assay results with DOI, DOM (1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane), DOB (1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane), LSD, lisuride hydrogen maleate and ergotamine). We also studied the effects of LY379268 on the head-twitch response behaviour, which is hallucinogen-specific 8, 9 . In a similar manner to its effects on G-protein activation and gene induction, the glutamate agonist LY379268 suppressed the induction of the head-twitch response by either DOI or LSD (Supplementary Fig. 11 ). These results suggest that LY379268 acts at the 2AR-mGluR2 complex to reduce the hallucinogen-specific G i/o signalling and behaviour. To establish further the functional relevance of 2AR-mGluR2 cross-talk, we compared the responses to the mGluR2/3 antagonist LY341494 in htr2A 1/1 and htr2A 2/2 mice. The locomotor and vertical activities elicited by LY341495 were significantly attenuated in the htr2A 2/2 mice (Fig. 3c) , supporting the functional relevance of the 2AR-mGluR2 complex in vivo and suggesting that it also influences the endogenous response to glutamate.
The findings that G i/o regulation, which is necessary for the effects of hallucinogens 8 , is enhanced by the formation of the 2AR-mGluR2 complex and that activation of the mGluR2 component suppresses hallucinogen-specific signalling implicate this complex in the effects of hallucinogens. The neuropsychological effects of hallucinogenic drugs present commonalities with the psychosis of schizophrenia, and both conditions are accompanied by disruptions of cortical sensory processing 10, 11, [23] [24] [25] [26] [27] . We investigated whether the components of the 2AR-mGluR2 signalling complex are dysregulated in the brain cortex of subjects with schizophrenia. We determined the density of binding sites for 2AR and for mGluR2/3 in cortex from schizophrenic subjects and in controls who were matched by gender, age and post-mortem delay (Supplementary Tables 8 and 9 ). The receptor densities in cortical membranes from untreated schizophrenic subjects were significantly altered, showing increased 2AR levels and decreased mGluR2/3 levels (Fig. 4a, b) . mRNA assays showed that expression of mGluR2 but not mGluR3 was decreased in cortex from schizophrenic subjects (Fig. 4e) . The studies in mouse show that ]GTP-cS binding in membranes followed by immunoprecipitation with anti-Ga q/11 (top) or anti-Ga i1,2,3 (bottom). Cells stably expressing 2AR were transfected with mGluR2, mGluR3 or mGluR3DTM4,5. The potency of DOI activating Ga i1,2,3 was significantly increased when the 2AR was co-expressed with either mGluR2 or mGluR3DTM4,5, an effect abolished by 10 mM LY379268 (LY379) (P , 0.001 by F test). Data are means 6 s.e.m. for three experiments performed in triplicate. f, Ribbon backbone representation of the transmembrane helices of the 2AR-mGluR2 heteromer model, seen from the intracellular face.
activation of the mGluR2 component of the 2AR-mGluR2 complex eliminates the hallucinogen-specific component of the signalling responses to LSD-like drugs. Thus, the increased 2AR and decreased mGluR2 found in the brain in schizophrenia may predispose to a hallucinogenic pattern of signalling.
Many laboratories have attempted to determine the density of 2AR in post-mortem brain from subjects with schizophrenia, and some studies have reported decreased or unchanged 2AR densities 28 . To try to understand the basis for these discrepancies from our results, we first studied the effects of chronic antipsychotic treatment on the 2AR and mGluR2 in mouse. The chronic atypical antipsychotic clozapine specifically downregulated the level of expression of 2AR and of mGluR2 in mouse SCx (Supplementary Fig. 12 ) Fig. 12 ) and was not induced by the chronic typical antipsychotic haloperidol (Supplementary Fig. 13 ). In concordance with the effects of clozapine in murine models, the density of 2AR was reduced to control levels in postmortem human brain cortex of schizophrenics treated with atypical antipsychotic drugs (Fig. 4c) , and the mGluR2/3-binding sites were also downregulated (Fig. 4d) . The onset of psychosis in schizophrenia usually occurs in later adolescence or early adulthood 1 . We studied the relationship of receptor densities with ageing: both [ Supplementary Fig. 14) . Hallucinations and delusions typically attenuate with ageing 29 , which correlates with the lower density of the components of the 2AR-mGluR2 complex that we observed in older subjects. Consequently, the marked dysregulation of both 2AR and mGluR2 expression in schizophrenia would be unlikely to be observed in samples from heterogeneous groups including treated patients 28 or in studies including older patients 28, 30 . These studies identify the 2AR-mGluR2 complex as a possible site of action of hallucinogenic drugs. The glutamate and serotonin systems have both been implicated in psychotic disorders, and the components of this complex are found to be differentially regulated in cortex from individuals with schizophrenia. Our results are consistent with the hypothesis that the 2AR-mGluR2 complex integrates serotonin and glutamate signalling to regulate the sensory gating functions of the cortex, a process that is disrupted in psychosis. 
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2/2 mice, the effect of LY341495 on distance was decreased (P , 0.05; Bonferroni's post hoc test of two-factor analysis of variance), and its effect on vertical activity was absent (n 5 30-32). Error bars show s.e.m. e, mGluR2 mRNA expression is decreased in untreated schizophrenic subjects (n 5 7) compared with matched control subjects (n 5 7; asterisk, P , 0.05; error bars show s.e.m.).
METHODS SUMMARY
All reagents were purchased from commercial vendors except for LY379268 (Eli Lilly and Co.). Mouse lines, treatment protocols, behavioural studies, dissections, and primary neuronal cultures, approved by Institutional Use and Care Committees, have been described previously 8, 9 . Protocols used for FISH 8 , binding assays 8 , real-time PCR 8 , FRET 17 and co-immunoprecipitation 17 were performed as described previously or with minor modifications. Epitope-tagged, BRET2, FRET and chimaera receptor constructs were generated by using standard cloning techniques and were confirmed by sequencing. BRET2 using Renilla luciferase and green fluorescent protein (GFP2) was performed in HEK-293 cells. Matched schizophrenia and control human brains were obtained from autopsies performed in the Basque Institute of Legal Medicine, Bilbao, Spain, in compliance with policies of research and ethical review boards for post-mortem brain studies.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
